203 related articles for article (PubMed ID: 17850789)
1. Prostaglandin E2 regulates melanocyte dendrite formation through activation of PKCzeta.
Scott G; Fricke A; Fender A; McClelland L; Jacobs S
Exp Cell Res; 2007 Nov; 313(18):3840-50. PubMed ID: 17850789
[TBL] [Abstract][Full Text] [Related]
2. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity.
Scott G; Leopardi S; Printup S; Malhi N; Seiberg M; Lapoint R
J Invest Dermatol; 2004 May; 122(5):1214-24. PubMed ID: 15140225
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidylcholine mediates melanocyte dendricity through PKCzeta activation.
Scott GA; Arioka M; Jacobs SE
J Invest Dermatol; 2007 Mar; 127(3):668-75. PubMed ID: 17024099
[TBL] [Abstract][Full Text] [Related]
4. PGE(2) is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation.
Starner RJ; McClelland L; Abdel-Malek Z; Fricke A; Scott G
Exp Dermatol; 2010 Jul; 19(7):682-4. PubMed ID: 20500768
[TBL] [Abstract][Full Text] [Related]
5. The cAMP signaling pathway has opposing effects on Rac and Rho in B16F10 cells: implications for dendrite formation in melanocytic cells.
Scott G; Leopardi S
Pigment Cell Res; 2003 Apr; 16(2):139-48. PubMed ID: 12622791
[TBL] [Abstract][Full Text] [Related]
6. Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.
Reid HM; Kinsella BT
Br J Pharmacol; 2009 Oct; 158(3):830-47. PubMed ID: 19702786
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
Walch L; Clavarino E; Morris PL
Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 inhibits the phospholipase D pathway stimulated by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Involvement of EP2 receptors and phosphatidylinositol 3-kinase gamma.
Burelout C; Thibault N; Levasseur S; Simard S; Naccache PH; Bourgoin SG
Mol Pharmacol; 2004 Aug; 66(2):293-301. PubMed ID: 15266020
[TBL] [Abstract][Full Text] [Related]
9. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production.
Nguyen M; Solle M; Audoly LP; Tilley SL; Stock JL; McNeish JD; Coffman TM; Dombrowicz D; Koller BH
J Immunol; 2002 Oct; 169(8):4586-93. PubMed ID: 12370397
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
[TBL] [Abstract][Full Text] [Related]
11. Characterization of PGE(2) receptors (EP) and their role as mediators of 1alpha,25-(OH)(2)D(3) effects on growth zone chondrocytes.
Sylvia VL; Del Toro F; Hardin RR; Dean DD; Boyan BD; Schwartz Z
J Steroid Biochem Mol Biol; 2001 Sep; 78(3):261-74. PubMed ID: 11595507
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes.
Harizi H; Grosset C; Gualde N
J Leukoc Biol; 2003 Jun; 73(6):756-63. PubMed ID: 12773508
[TBL] [Abstract][Full Text] [Related]
13. Receptors and pathways mediating the effects of prostaglandin E2 on airway tone.
Tilley SL; Hartney JM; Erikson CJ; Jania C; Nguyen M; Stock J; McNeisch J; Valancius C; Panettieri RA; Penn RB; Koller BH
Am J Physiol Lung Cell Mol Physiol; 2003 Apr; 284(4):L599-606. PubMed ID: 12618422
[TBL] [Abstract][Full Text] [Related]
14. Prevotella intermedia induces prostaglandin E2 via multiple signaling pathways.
Guan SM; Fu SM; He JJ; Zhang M
J Dent Res; 2011 Jan; 90(1):121-7. PubMed ID: 21057037
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
Li YJ; Wang XQ; Sato T; Kanaji N; Nakanishi M; Kim M; Michalski J; Nelson AJ; Sun JH; Farid M; Basma H; Patil A; Toews ML; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):99-107. PubMed ID: 20203295
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes.
Richards JA; Brueggemeier RW
J Clin Endocrinol Metab; 2003 Jun; 88(6):2810-6. PubMed ID: 12788892
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase Calpha, and c-Src pathway in primary cultured rat osteoblasts.
Tang CH; Yang RS; Fu WM
J Biol Chem; 2005 Jun; 280(24):22907-16. PubMed ID: 15833739
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the human prostanoid TPalpha and TPbeta receptor isoforms mediated through activation of the EP(1) and IP receptors.
Walsh MT; Kinsella BT
Br J Pharmacol; 2000 Oct; 131(3):601-9. PubMed ID: 11015313
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the pronounced synergism between prostaglandin E2 and other constrictor agents on rat femoral artery.
Hung GH; Jones RL; Lam FF; Chan KM; Hidaka H; Suzuki M; Sasaki Y
Prostaglandins Leukot Essent Fatty Acids; 2006 Jun; 74(6):401-15. PubMed ID: 16737803
[TBL] [Abstract][Full Text] [Related]
20. sPLA2-X stimulates cutaneous melanocyte dendricity and pigmentation through a lysophosphatidylcholine-dependent mechanism.
Scott GA; Jacobs SE; Pentland AP
J Invest Dermatol; 2006 Apr; 126(4):855-61. PubMed ID: 16456529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
